EUVIMEDEUVIMED entdecken
Editorial

Advanced Therapy for Intermediate-Risk Pulmonary Embolism

Alex C Spyropoulos, Suresh Vedantham

New England Journal of Medicine · 28.05.2026 · 394 (20) · 2052-2054

DOI: 10.1056/nejme2603115 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, erschienen am 28.05.2026. Verfasst von Alex C Spyropoulos und 1 weiteren Autor:innen. Beteiligte Einrichtung: Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY.
  • Feinstein Institutes for Medical Research, Manhasset, NY.
  • Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York.
  • Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis.

Zitieren

APA

Spyropoulos, A. C., & Vedantham, S. (2026). Advanced Therapy for Intermediate-Risk Pulmonary Embolism. New England Journal of Medicine, 394(20), 2052-2054. https://doi.org/10.1056/nejme2603115

Vancouver

Spyropoulos AC, Vedantham S. Advanced Therapy for Intermediate-Risk Pulmonary Embolism. New England Journal of Medicine. 2026;394(20):2052-2054. doi:10.1056/nejme2603115

BibTeX
@article{Spyropoulos2026,
  author = {Spyropoulos, Alex C and Vedantham, Suresh},
  title = {Advanced Therapy for Intermediate-Risk Pulmonary Embolism},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {20},
  pages = {2052--2054},
  doi = {10.1056/nejme2603115}
}
Kostenlos starten →